Eastgate Biotech Stock

Eastgate Biotech ROA

Return on Assets (ROA) of Eastgate Biotech (ETBI) as of Aug 16, 2026.

ROA

0.00

Last updated:

In 2026, Eastgate Biotech's return on assets (ROA) was 0.00, a % increase from the -1,437.07 % ROA in the previous year.

Access this data via the Eulerpool API

Eastgate Biotech Stock analysis

What does Eastgate Biotech do? Eastgate Biotech Corp is a biotechnology company specialized in the development and marketing of natural nutritional products and medicines. The company was founded in Canada in 1999 and is headquartered in Toronto. Eastgate Biotech Corp is listed on the Canadian Securities Exchange and is one of the leading companies in the field of biological medicine. The company's business model is based on the research and development of natural supplements and medicines made from plant and animal ingredients. Eastgate Biotech Corp aims to develop products that improve the well-being of humans and animals and can be manufactured in a natural way. The company relies on the use of innovative technologies and advanced research methods. Eastgate Biotech Corp operates in various sectors including medicine, animal health, and agricultural production. In the field of medicine, the company specializes in the development of medicines for the treatment of various diseases. It uses plant and animal ingredients to create natural remedies. In the animal health sector, Eastgate Biotech Corp offers products specifically designed for the health and well-being of livestock. The company is also involved in agricultural production, offering products that contribute to increasing crop yields. The range of products offered by Eastgate Biotech Corp includes a wide variety of nutritional supplements and medicines. The company offers products that support a healthy diet and help meet the needs for vitamins and minerals. Additionally, Eastgate Biotech Corp offers products that help strengthen the immune system, lower cholesterol levels, or regulate blood pressure. Products for weight control and metabolism support are also available. Some of the most well-known products from Eastgate Biotech Corp include the nutritional supplements "Celergen" and "Deltaweight". "Celergen" is a highly effective preparation that can help increase physical performance, smooth the skin, and improve mental fitness. "Deltaweight" is a nutritional supplement specifically developed for those looking to lose weight or maintain their weight. The product contains a unique blend of natural ingredients that can stimulate metabolism and reduce appetite. Eastgate Biotech Corp has undergone impressive development in recent years and is now one of the leading companies in the field of biological medicine. The company has an experienced team of scientists and experts who support the development of new products. Eastgate Biotech Corp relies on the use of advanced research methods and innovative technologies to manufacture new preparations that can improve the well-being of humans and animals in a natural way. Eastgate Biotech is one of the most popular companies on Eulerpool.

ROA Details

Understanding Eastgate Biotech's Return on Assets (ROA)

Eastgate Biotech's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Eastgate Biotech's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Eastgate Biotech's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Eastgate Biotech’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Eastgate Biotech stock

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Eastgate Biotech since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Eastgate Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

Profitability — Eastgate Biotech

All Key Metrics — Eastgate Biotech